MedTrace Logo

Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome.

NCT01297556 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2011-02-16

No results posted yet for this study

Summary

The purpose of this study is to determine if any specific patient characteristics lead to improved outcome of IBS treatment, when conventional treatment as well as Cognitive Behavioral Therapy is used in combination.

Conditions

  • Irritable Bowel Syndrome

Interventions

BEHAVIORAL

Cognitive Behavior Therapy(CBT)

Cognitive Behavior Therapy(CBT) for 6 weeks.

Sponsors & Collaborators

  • Michigan Gastroenterology Institute

    lead OTHER

Principal Investigators

  • Iftiker Ahmad, M.D. · Michigan Gastroenterology Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01297556 on ClinicalTrials.gov